• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2019)
Mohamad, S. (2020). COMPARISON OF THE SERUM LEVEL OF MATRIX METALLOPROTINASE-3 IN PSORIASIS PATIENTS WITHH AND WITHOUT PSORIATIC ARTHRITIS. ALEXMED ePosters, 2(2), 65-65. doi: 10.21608/alexpo.2020.49252.1069
Sara Saeed Mohamad. "COMPARISON OF THE SERUM LEVEL OF MATRIX METALLOPROTINASE-3 IN PSORIASIS PATIENTS WITHH AND WITHOUT PSORIATIC ARTHRITIS". ALEXMED ePosters, 2, 2, 2020, 65-65. doi: 10.21608/alexpo.2020.49252.1069
Mohamad, S. (2020). 'COMPARISON OF THE SERUM LEVEL OF MATRIX METALLOPROTINASE-3 IN PSORIASIS PATIENTS WITHH AND WITHOUT PSORIATIC ARTHRITIS', ALEXMED ePosters, 2(2), pp. 65-65. doi: 10.21608/alexpo.2020.49252.1069
Mohamad, S. COMPARISON OF THE SERUM LEVEL OF MATRIX METALLOPROTINASE-3 IN PSORIASIS PATIENTS WITHH AND WITHOUT PSORIATIC ARTHRITIS. ALEXMED ePosters, 2020; 2(2): 65-65. doi: 10.21608/alexpo.2020.49252.1069

COMPARISON OF THE SERUM LEVEL OF MATRIX METALLOPROTINASE-3 IN PSORIASIS PATIENTS WITHH AND WITHOUT PSORIATIC ARTHRITIS

Article 31, Volume 2, Issue 2, October 2020, Page 65-65  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.49252.1069
View on SCiNiTO View on SCiNiTO
Author
Sara Saeed Mohamad email
Department of dermatology,venreology and andrology
Abstract
Psoriasis is a common chronic inflammatory immune mediated multifactorial disorder affecting the skinwhich is increasingly recognized as a systemic inflammatory disease. Psoriasis affects approximately about 2%‐3% of the population worldwide.
Psoriatic arthritis is one of the frequent complications of psoriasis that may affect 30% of psoriatic patients, it is a musculoskeletal inflammatory disorder affecting axial and peripheral joints with extra-articular manifestations.
Early diagnosis and recognition of psoriatic arthritis and its management will improve the quality of life and decrease complications. Detection of serum biomarker for psoriatic arthritis may help in early diagnose.
Matrix metalloproteinase 3 (MMP3) is a zinc dependent endopeptidase also known as Stromelysin-1. It plays a role in degradation of extracellular matrix, tissue remodling and also in diseases processes. Matrix metalloproteinase 3 serum level increases in rheumatic disease and other non-rheumatic diseases as systemic lupus and glomerulonephritis respectively. It has been used as a synovial marker for joint inflammation and tissue destruction.
The aim of this study was to compare the serum level of matrix metalloproteinase 3 in psoriasis patients with and without psoriatic arthritis and to detect its correlation with disease severity.
Keywords
Psoriasis; psoriatic arthritis; MMP3
Statistics
Article View: 161
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.